Tanabe Research Laboratories USA Inc (AKA: Immunetech Pharmaceuticals~Dura Pharmaceuticals) Profile last edited on: 10/31/22
CAGE:
UEI:
Business Identifier: NO Business Identifier is currently available for this company. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 52
County: San Diego
Congr. District: 52
County: San Diego
Public Profile
Having previously receivd awards as Immunetech Pharmaceuticals, the firm is now known as Tanabe Research Laboratories U.S.A., Inc. (TRL), and is a wholly owned subsidiary of Tanabe Seiyaku Co., Ltd., that is headquartered in Osaka, Japan. Withthe subsiduary firm remaining in originall location the focus of TRL is defined as being that to discover, optimize and develop innovative pharmaceutical products to address unmet medical needs in major therapeutic categories. Tanabe Research Laboratories had been initially focused on small molecule drug discovery in the field of metabolics and inflammation/immunology. At the beginning of 2010, the organization was restructured to direct efforts towards biologics instead of small molecule compounds
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
25-49Revenue Range
2.5M-5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
25-49Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 1990 | 1 | NIH | $48,650 | |
| Project Title: Development of interleuken 6 antagonists | ||||
| 1990 | 1 | NIH | $50,000 | |
| Project Title: Isolation of potential marine anti-arthritic drugs | ||||
Key People / Management
Taka Shikiyoizemi -- President
Wolfgang Scholtz
Wolfgang Scholtz
Company News
There are no news available.
